Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 125(4): 668-79, 2015 Jan 22.
Article in English | MEDLINE | ID: mdl-25428220

ABSTRACT

Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma in the Western world. FL cell-intrinsic and cell-extrinsic factors influence FL biology and clinical outcome. To further our understanding of the genetic basis of FL, we performed whole-exome sequencing of 23 highly purified FL cases and 1 transformed FL case and expanded findings to a combined total of 114 FLs. We report recurrent mutations in the transcription factor STAT6 in 11% of FLs and identified the STAT6 amino acid residue 419 as a novel STAT6 mutation hotspot (p.419D/G, p.419D/A, and p.419D/H). FL-associated STAT6 mutations were activating, as evidenced by increased transactivation in HEK293T cell-based transfection/luciferase reporter assays, heightened interleukin-4 (IL-4) -induced activation of target genes in stable STAT6 transfected lymphoma cell lines, and elevated baseline expression levels of STAT6 target genes in primary FL B cells harboring mutant STAT6. Mechanistically, FL-associated STAT6 mutations facilitated nuclear residency of STAT6, independent of IL-4-induced STAT6-Y641 phosphorylation. Structural modeling of STAT6 based on the structure of the STAT1-DNA complex revealed that most FL-associated STAT6 mutants locate to the STAT6-DNA interface, potentially facilitating heightened interactions. The genetic and functional data combined strengthen the recognition of the IL-4/JAK/STAT6 axis as a driver of FL pathogenesis.


Subject(s)
Cell Nucleus/metabolism , Gene Expression Regulation, Neoplastic , Lymphoma, Follicular/metabolism , Mutation, Missense , Neoplasm Proteins/metabolism , STAT6 Transcription Factor/metabolism , Active Transport, Cell Nucleus/genetics , Cell Line, Tumor , Cell Nucleus/genetics , Genome-Wide Association Study , HEK293 Cells , Humans , Interleukin-4/genetics , Interleukin-4/metabolism , Janus Kinases/genetics , Janus Kinases/metabolism , Lymphoma, Follicular/genetics , Lymphoma, Follicular/pathology , Neoplasm Proteins/genetics , Phosphorylation/genetics , STAT6 Transcription Factor/genetics , Transcriptional Activation/genetics
2.
Blood ; 123(10): 1487-98, 2014 Mar 06.
Article in English | MEDLINE | ID: mdl-24435047

ABSTRACT

Follicular lymphoma (FL) constitutes the second most common non-Hodgkin lymphoma in the western world. FL carries characteristic recurrent structural genomic aberrations. However, information regarding the coding genome in FL is still evolving. Here, we describe the results of massively parallel exome sequencing and single nucleotide polymorphism 6.0 array genomic profiling of 11 highly purified FL cases, and 1 transformed FL case and the validation of selected mutations in 102 FL cases. We report the identification of 15 novel recurrently mutated genes in FL. These include frequent mutations in the linker histone genes HIST1H1 B-E (27%) and mutations in OCT2 (also known as POU2F2; 8%), IRF8 (6%), and ARID1A (11%). A subset of the mutations in HIST1H1 B-E affected binding to DNMT3B, and mutations in HIST1H1 B-E and in EZH2 or ARID1A were largely mutually exclusive, implicating HIST1H1 B-E in epigenetic deregulation in FL. Mutations in OCT2 (POU2F2) affected its transcriptional and functional properties as measured through luciferase assays, the biological analysis of stably transduced cell lines, and global expression profiling. Finally, multiple novel mutated genes located within regions of acquired uniparental disomy in FL are identified. In aggregate, these data substantially broaden our understanding of the genomic pathogenesis of FL.


Subject(s)
Histones/genetics , Interferon Regulatory Factors/genetics , Lymphoma, Follicular/genetics , Mutation , Nuclear Proteins/genetics , Octamer Transcription Factor-2 , Amino Acid Sequence , CREB-Binding Protein/genetics , DNA Mutational Analysis , DNA-Binding Proteins/genetics , Enhancer of Zeste Homolog 2 Protein , Epigenesis, Genetic , Exome , High-Throughput Nucleotide Sequencing , Histones/chemistry , Humans , Molecular Sequence Data , Neoplasm Proteins/genetics , Polycomb Repressive Complex 2/genetics , Polymorphism, Single Nucleotide , Proto-Oncogene Proteins c-bcl-2/genetics , Receptors, Tumor Necrosis Factor, Member 14/genetics , Sequence Alignment , Transcription Factors , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...